2016-03-07T00:00:00.000-05:00
recent multicountry study,0.306603
colistin resistance,-0.639482
United States,-0.566142
new antibiotics,-0.60851
new ways,0.483631
new classes,-0.521709
antibiotic research,0.402758
community-acquired MRSA,-0.692428
methicillin-resistant Staphylococcus aureus,-0.528966
infectious diseases,-0.747636
World Health Organization,0.462925
largest pharmaceutical companies,-0.299788
Biomedical Advanced Research,0.585348
entire drug industry,0.339356
new drug investment,0.368377
colistin-resistant E coli,-0.488037
Drug Administration,-0.547253
antibiotics,-0.520967
susceptible strains,-0.518032
new drugs,0.585348
resistant strains,-0.375111
resistant E coli,-0.682068
Huge public support,-0.521709
huge immediate market,-0.236229
resistant ones,-0.518032
federal budget agreement,-0.626637
new types,-0.592659
antibiotic overuse,-0.949589
Lancet Infectious Diseases,-0.729938
threat infectious diseases,-0.933461
bacteria,-0.251499
antibiotic resistance research,0.428598
completely different strains,-0.551894
recent worry,-0.321567
antibiotic market,-0.299788
pharmaceutical companies,-0.466906
